Evaluating India’s Position in Pragmatic Clinical Trial for Public Healthcare: A Key to Real World Healthcare Solutions

Smruti Besekar; Sangita Jogdand; Satyawan Singh  Patel

doi:10.55489/njcm.151220244683

Authors

Smruti Besekar Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, India
Sangita Jogdand Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Sawangi, India
Satyawan Singh Patel Datta Meghe Institute of Higher Education and Research, Sawangi, India

DOI:

https://doi.org/10.55489/njcm.151220244683

Keywords:

PRECIS-2, Pragmatic clinical trial, India, Real world evidence

Abstract

Pragmatic Clinical Trials (PCTs) are valuable tools for evaluating interventions in real-world settings, providing insights for clinical practice. Unlike traditional randomized controlled trial (RCTs), PCTs generate real-world evidence for better decision-making. With 615 reported globally between 1967 and 2017, a 58% increase from 2013 to 2017, India has only one registered PCT, indicating a gap in its adoption. This review examines national clinical trial registries, PubMed database for PCTs till 2024, comparing data across different nations. The study reveals a significant shortage of PCTs in India and a lack of awareness of frameworks like Pragmatic Explanatory Continuum Indicator Summary 2. India faces challenges in implementing PCTs due to low awareness, inadequate infrastructure, and logistical hurdles. However, with regulatory reforms, international collaboration, and infrastructure improvements, India can become a key player in advancing PCTs. Increased awareness and researcher training will contribute to better healthcare outcomes both domestically and globally.

References

Weinfurt KP, Hernandez AF, Coronado GD, DeBar LL, Dember LM, Green BB, et al. Pragmatic clinical trials embedded in healthcare systems: generalizable lessons from the NIH Collaboratory. BMC Med Res Methodol. 2017 Sep 18;17:144. DOI: https://doi.org/10.1186/s12874-017-0420-7 PMid:28923013 PMCid:PMC5604499

Dal-Ré R, Janiaud P, Ioannidis JPA. Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic? BMC Med. 2018 Apr 3;16:49. DOI: https://doi.org/10.1186/s12916-018-1038-2 PMid:29615035 PMCid:PMC5883397

Gamerman, V., Cai, T. & Elsäßer, A. Pragmatic randomized clinical trials: best practices and statistical guidance. Health Serv Outcomes Res Method 19, 23-35 (2019). DOI: https://doi.org/10.1007/s10742-018-0192-5

Glasziou P, Matthews R, Boutron I, Chalmers I, Armitage P. The differences and overlaps between 'explanatory' and 'pragmatic' controlled trials: a historical perspective. Journal of the Royal Society of Medicine. 2023;116(12):425-432. DOI: https://doi.org/10.1177/01410768231207536 PMid:37991449

Jeong NY, Kim SH, Lim E, Choi NK. Pragmatic Clinical Trials for Real-World Evidence: Concept and Implementation. Cardiovasc Prev Pharmacother. 2020;2(3):85-98. DOI: https://doi.org/10.36011/cpp.2020.2.e12

Rosenthal GE. The role of pragmatic clinical trials in the evolution of learning health systems. Trans Am Clin Climatol Assoc. 2014;125:204-16; discussion 217-8. PMID: 25125735; PMCID: PMC4112713.

Norton WE, Loudon K, Chambers DA, Zwarenstein M. Designing provider-focused implementation trials with purpose and intent: introducing the PRECIS-2-PS tool. Implement Sci IS. 2021 Jan 7;16:7. DOI: https://doi.org/10.1186/s13012-020-01075-y PMid:33413489 PMCid:PMC7791810

Dang A, Kaur K. Comparative effectiveness research and its utility in In-clinic practice. Perspect Clin Res. 2016 Jan-Mar;7(1):9-14. DOI: https://doi.org/10.4103/2229-3485.173780 PMid:26955571 PMCid:PMC4763521

Sarri G, Iheanacho I. Is Real-World Evidence Needed in Comparative Effectiveness Research? Yes, But …. (2018). Available from: https://www.evidera.com/wp-content/uploads/2018/05/Is-Real-World-Evidence-Needed.pdf

Suvarnapathaki K. Indian regulatory update 2013. Perspect Clin Res. 2013;4(4):237-8. DOI: https://doi.org/10.4103/2229-3485.120174 PMid:24312893 PMCid:PMC3835969

India accounts for 6.2% share of global clinical trial activity in 2021 - Clinical Trials Arena [Internet]. [cited 2024 Sep 10]. Available from: https://www.clinicaltrialsarena.com/marketdata/india-accounts-for-6-2-share-of-global-clinical-trial-activity-in-2021/

Evans SR. Fundamentals of clinical trial design. J Exp Stroke Transl Med. 2010 Jan 1;3(1):19-27. DOI: https://doi.org/10.6030/1939-067X-3.1.19 PMid:21533012 PMCid:PMC3083073

Roy R, Mehta D. Regulatory development in the conduct of clinical trials in India. Global Health Epidemiology Genomic. 2016 Feb 23;1:e4. DOI: https://doi.org/10.1017/gheg.2015.5 PMid:29868198 PMCid:PMC5870412

Esteban I, Ferreira JC, Patino CM. Why is conducting pragmatic clinical trials so important? J Bras Pneumol. 48(5):e20220397. DOI: https://doi.org/10.36416/1806-3756/e20220397 PMid:36383783 PMCid:PMC9747146

The rise of India as a hub for clinical trials: Factors, regulations & opportunities [Internet]. [cited 2024 Sep 10]. Available from: https://pharmabiz.com/ArticleDetails.aspx?aid=165120&sid=9

Poongothai S, Unnikrishnan R, Balasubramanian J, Nair MD, Mohan V. Why are clinical trials necessary in India? Perspect Clin Res. 2014;5(2):55-9. DOI: https://doi.org/10.4103/2229-3485.128018 PMid:24741480 PMCid:PMC3980544

Shivabasappa S, Srinivasan A. Complexity of clinical trial operationalisation in India. Lancet Glob Health. 2022 Jul 1;10(7):e953. DOI: https://doi.org/10.1016/S2214-109X(22)00209-1 PMid:35714642

Pragmatic Clinical Trials: Testing Treatments in the Real-World [Internet]. [cited 2024 Sep 10]. Available from: https://capra.ca/en/blog/pragmatic-clinical-trials-testing-treatments-in-the-real-world-2022-10-17

REaCT: REthinking Clinical Trials [Internet]. [cited 2024 Sep 10]. Available from: https://react.ohri.ca/

Omerovic, Elmir & Petrie, Mark & Redfors, Björn & Fremes, Stephen & Murphy, Gavin & Gravel, Guillaume & Lansky, Alexandra & Velazquez, Eric & Perera, Divaka & Reid, Christopher & Smith, Julian & Meer, Peter & Lipsic, Erik & Juni, Peter & McMurray, John & Bauersachs, Johann & Køber, Lars & Rouleau, Jean & Doenst, Torsten. (2024). Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9-Pragmatic Research and Innovation through Multinational Experimentation. Trials. 25. 10.1186/s13063-024-07935-y. DOI: https://doi.org/10.1186/s13063-024-07935-y PMid:38263138 PMCid:PMC10807265

White, R. (2023). Building trust in real world evidence (RWE): moving transparency in RWE towards the randomized controlled trial standard. Current Medical Research and Opinion, 39(12), 1737-1741. DOI: https://doi.org/10.1080/03007995.2023.2263353 PMid:37787381

Patsopoulos NA. A pragmatic view on pragmatic trials. Dialogues Clin Neurosci. 2011;13(2):217-24. doi: 10.31887/DCNS.2011.13.2/npatsopoulos. PMID: 21842619; PMCID: PMC3181997.

Nk C, J A, Rj G, Em A, S S, M T, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med [Internet]. 2011 Jan 12 [cited 2024 Oct 5];365(22). Available from: https://pubmed.ncbi.nlm.nih.gov/22080794/

Fröbert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013 Oct 24;369(17):1587-97. DOI: https://doi.org/10.1056/NEJMoa1308789 PMid:23991656

Ford I, Norrie J. Pragmatic Trials. N Engl J Med. 2016 Aug 4;375(5):454-63. DOI: https://doi.org/10.1056/NEJMra1510059 PMid:27518663

Morain SR, Mathews DJH, Geller G, Bollinger J, Weinfurt K, Jarvik JG, et al. Identification and Management of Pragmatic Clinical Trial Collateral Findings: A Current Understanding and Directions for Future Research. Healthc Amst Neth. 2021 Dec;9(4):100586. DOI: https://doi.org/10.1016/j.hjdsi.2021.100586 PMid:34600345 PMCid:PMC8664991

Sindakis, S., Showkat, G. The digital revolution in India: bridging the gap in rural technology adoption. J Innov Entrep 13, 29 (2024). https://doi.org/10.1186/s13731-024-00380-w

Richesson RL, Marsolo KS, Douthit BJ, Staman K, Ho PM, Dailey D, et al. Enhancing the use of EHR systems for pragmatic embedded research: lessons from the NIH Health Care Systems Research Collaboratory. J Am Med Inform Assoc JAMIA. 2021 Oct 1;28(12):2626-40. DOI: https://doi.org/10.1093/jamia/ocab202 PMid:34597383 PMCid:PMC8633608

Institute of Medicine (US). Envisioning a Transformed Clinical Trials Enterprise in the United States: Establishing An Agenda for 2020: Workshop Summary. Washington (DC): National Academies Press (US); 2012. Appendix G, Discussion Paper: Developing a Clinical Trials Infrastructure. Available from: https://www.ncbi.nlm.nih.gov/books/NBK114674/